PubMed · 15736430
Chkl binds and phosphorylates BAD protein.
Abstract
Chk1 (checkpoint kinase 1) is a serine-threonine kinase that is critical for G2/M arrest in response to DNA damage. Chk1 phosphorylates Cdc25C at serine-216, a major regulatory site, in response to DNA damage. Furthermore, Chk1 also phosphorylates Cdc25A on serine 123 which accelerates its degradation through the ubiquitin-proteasome pathway and arrests cells in late G2-phase after DNA damage. In the present study, we demonstrated that Chk1 phosphorylates pro-apoptotic protein BAD (Bcl-2/Bcl-XL-Antagonist, causing cell Death) in vitro. In vitro phosphorylation analysis with various mouse BAD peptides has revealed two phosphorylation sites for Chk1 at serine-155 and serine-170. When wild-type and mutant BAD (S155A) constructs were transfected into 293T cells, an association between BAD and Chk1 was observed by co-immunoprecipitation. In addition, there was an increase in the phosphorylation of serine-155 following DNA damage by adriamycin treatment. Our results suggest that Chk1 associates with BAD and phosphorylates the BAD protein at serine-155. Taken together, our results suggest that Chk1 may inactivate BAD by associating with and phosphorylating residues critical for BAD function in response to DNA damage.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Edward Kyu-ho Han, Chris Butler, Haichao Zhang, Jean M Severin, Wenying Qin, Tom F Holzman, Earl J Gubbins, Robert L Simmer, Saul Rosenberg, Vincent L Giranda, Shi-Chung Ng, Y Luo. Chkl binds and phosphorylates BAD protein.. https://pubmed.ncbi.nlm.nih.gov/15736430/
Cite the original work for its findings. Save a collection to share your selection of sources.